Stockscreener 앱 받기
1.71
0.29%
-0.005
시간 외 거래:
1.64
-0.07
-4.09%
전일 마감가:
$1.715
열려 있는:
$1.73
하루 거래량:
17,965
Relative Volume:
0.16
시가총액:
$17.89M
수익:
$10.16M
순이익/손실:
$-47.57M
주가수익비율:
-0.2075
EPS:
-8.24
순현금흐름:
$-42.73M
1주 성능:
+4.91%
1개월 성능:
-7.57%
6개월 성능:
-46.89%
1년 성능:
-61.96%
1일 변동 폭
$1.66
$1.7692
1주일 범위
$1.55
$1.82
52주 변동 폭
$1.02
$8.29
Curis Inc Stock (CRIS) Company Profile
명칭
Curis Inc
전화
617-503-6500
주소
128 SPRING STREET, LEXINGTON, MA
CRIS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CRIS
Curis Inc
|
1.71 | 20.04M | 10.16M | -47.57M | -42.73M | -8.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Curis Inc Stock (CRIS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-19 | 재개 | H.C. Wainwright | Buy |
| 2023-11-17 | 개시 | Truist | Buy |
| 2022-04-04 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2021-10-13 | 개시 | Raymond James | Outperform |
| 2021-03-25 | 개시 | B. Riley Securities | Buy |
| 2020-07-29 | 개시 | Laidlaw | Buy |
| 2020-07-17 | 개시 | Cantor Fitzgerald | Overweight |
| 2017-10-24 | 개시 | Guggenheim | Buy |
| 2016-03-02 | 개시 | Sun Trust Rbsn Humphrey | Buy |
| 2015-11-09 | 재확인 | ROTH Capital | Buy |
| 2015-08-11 | 개시 | FBR Capital | Outperform |
| 2015-01-22 | 재확인 | Oppenheimer | Outperform |
| 2015-01-21 | 재확인 | ROTH Capital | Buy |
| 2014-05-09 | 재확인 | Oppenheimer | Outperform |
| 2013-10-02 | 개시 | Robert W. Baird | Outperform |
| 2013-09-30 | 개시 | Chardan Capital Markets | Buy |
| 2012-11-14 | 개시 | Stifel Nicolaus | Hold |
| 2012-01-31 | 재확인 | Brean Murray | Buy |
| 2012-01-31 | 재확인 | Summer Street Research | Buy |
| 2011-12-09 | 개시 | Oppenheimer | Outperform |
| 2011-10-06 | 개시 | Summer Street Research | Buy |
| 2011-09-22 | 개시 | MLV Capital | Buy |
| 2011-03-21 | 재확인 | Brean Murray | Buy |
| 2010-02-26 | 재확인 | Roth Capital | Buy |
| 2010-01-07 | 개시 | Roth Capital | Buy |
모두보기
Curis Inc 주식(CRIS)의 최신 뉴스
What makes Curis Inc. stock price move sharplyGiant Leap Stock Alerts - thegnnews.com
Curis Files Prospectus Supplement for Stock Offering - MSN
Curis Inc. Receives Buy Rating Amid Promising Clinical Developments and Strong Financial Position - TipRanks
Curis targets enrolling 30–40 additional patients for NDA and EMA submissions as emavusertib studies advance - MSN
Curis, Inc. (NASDAQ:CRIS) Just Reported, And Analysts Assigned A US$16.33 Price Target - simplywall.st
Curis, Inc. Analysts Trim Price Target After Q2 Report - AInvest
Curis (CRIS) Reports Q2 Loss, Beats Revenue Estimates - MSN
Curis 2025 Q2 Earnings Narrowed Losses Amid Strong Revenue Growth - AInvest
Curis, Inc. shares rise 1.74% intraday as Swiss president meets business leaders in Washington ahead of tariff talks. - AInvest
Curis Inc (CRIS) Q2 2025 Earnings Call Highlights: Strategic Advances Amid Financial Challenges - Yahoo Finance
Curis, Inc. (NASDAQ:CRIS) Q2 2025 Earnings Call Transcript - Insider Monkey
Curis Provides Second Quarter 2025 Business Update - BioSpace
Curis: Q2 Earnings Snapshot - New Haven Register
Curis, Inc. Reports Q2 2025 Financial and Clinical Progress - TipRanks
Curis Inc. Earnings Call: Progress Amid Challenges - TipRanks
Curis Inc. Q2 Earnings Call Highlights: Progress Amid Challenges - AInvest
Curis (CRIS) Q2 Loss Narrows 66% - The Motley Fool
Curis Inc: Promising Financial Performance and Clinical Advancements Justify Buy Rating - TipRanks
Earnings call transcript: Curis Inc’s Q2 2025 sees reduced losses, stock rises - Investing.com
Earnings call transcript: Curis Inc’s Q2 2025 sees reduced losses, stock rises By Investing.com - Investing.com South Africa
Curis Inc: A High-Conviction Biotech Play with Accelerating Catalysts in Hematology - AInvest
Curis, Inc. Q2 2025: Unraveling Contradictions in Enrollment Strategy, FDA Dynamics, and PCNSL Data Expectations - AInvest
Curis Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Curis Inc (CRIS) Q2 2025 Earnings Report Preview: What To Expect - Yahoo Finance
How strong is Curis Inc. company’s balance sheetTrack top-performing stocks effortlessly - Jammu Links News
What are the technical indicators suggesting about Curis Inc.Exceptional gains - Jammu Links News
What catalysts could drive Curis Inc. stock higher in 2025Achieve breakthrough investment performance - Jammu Links News
How does Curis Inc. compare to its industry peersGet real-time updates on market trends - Jammu Links News
What drives Curis Inc. stock priceUnmatched market gains - Jammu Links News
What are Curis Inc. company’s key revenue driversInvest smarter with daily trading signals - Jammu Links News
What are analysts’ price targets for Curis Inc. in the next 12 monthsTurn volatility into profit opportunities - Jammu Links News
What is Curis Inc. company’s growth strategyBreakthrough financial growth - Jammu Links News
Is it the right time to buy Curis Inc. stockPhenomenal trading returns - Jammu Links News
Can machine learning forecast Curis Inc. recoverySmart Stock Forecast Using AI Algorithms - newser.com
Is Curis Inc. a growth stock or a value stockExtraordinary profit generation - Jammu Links News
What institutional investors are buying Curis Inc. stockMaximize your returns with expert insights - Jammu Links News
When is Curis Inc. stock expected to show significant growthHigh-margin investment plays - Jammu Links News
How Curis Inc. stock performs during market volatilitySmart Trend Analysis With Buy Point Cues - newser.com
What markets is TNET expanding into Is Curis Inc. stock a good long term investment optionSky-high return potential - Jammu Links News
Price Floor Holding on Curis Inc. — Rebound PossibleReversal Alert Based on RSI Indicator Confirmed - beatles.ru
Curis Inc expected to post a loss of 89 cents a shareEarnings Preview - TradingView
Why is Curis Inc. stock attracting strong analyst attentionBeginner Investor Ideas For Smart Trading - Jammu Links News
Curis Inc (CRIS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):